Die Stellenanzeige ist nicht mehr verfügbar...
- Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of technologies to address a patient's unmet clinical needs. It's our driving force to help patients live longer and healthier lives. Join us and be part of our inspiring journey. Since 2017, Edwards TMTT launched... |
- Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of technologies to address a patient's unmet clinical needs. It's our driving force to help patients live longer and healthier lives. Join us and be part of our inspiring... |
- Aortic stenosis impacts millions of people globally, yet it often remains underdiagnosed and undertreated. Edwards' groundbreaking work in transcatheter aortic heart valve replacement (TAVR) pioneered an innovative, lifechanging solution for patients by offering heart valve replacement without the need for open heart surgery. Our Transcatheter Heart Valve (THV) business unit continues to partner with cardiologists and clinical teams to... |
- Aortic stenosis impacts millions of people globally, yet it often remains underdiagnosed and undertreated. Edwards' groundbreaking work in transcatheter aortic heart valve replacement (TAVR) pioneered an innovative, lifechanging solution for patients by offering heart valve replacement without the need for open heart surgery. Our Transcatheter Heart Valve (THV) business unit continues to partner with cardiologists and clinical teams to... |
- Edwards Lifesciences ist ein führender Anbieter von Produkten und Technologien zur Behandlung fortgeschrittener Herz- und Gefäßerkrankungen und der weltweit größte Anbieter von Herzklappen. Edwards, mit Unternehmenshauptsitz in Irvine, US-Bundesstaat Kalifornien, beschäftigt weltweit mehr als 15.000 Mitarbeiter. In Deutschland sind derzeit über 300 Mitarbeiter tätig. Das Unternehmen vermarktet medizinische Produkte in mehr als 100... |
- Innovation starts from the heart. Edwards Lifesciences is the global leader of patientfocused innovations for structural heart disease . With millions of patients served in over 100 countries, each team makes a meaningful contribution by improving patient outcomes and discovering lasting solutions for unmet patient needs. This role will be responsible for Marketing in Edwards Mitral and Tricuspid Therapies Business Unit for Germany. In this... |
|
- Aortic stenosis impacts millions of people globally, yet it often remains underdiagnosed and undertreated. Edwards' groundbreaking work in transcatheter aortic heart valve replacement (TAVR) pioneered an innovative, lifechanging solution for patients by offering heart valve replacement without the need for open heart surgery. Our Transcatheter Heart Valve (THV) business unit continues to partner with cardiologists and clinical teams to... |
